These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 17068402

  • 1. [Hormone replacement therapy for internal risk patients].
    Mueck AO.
    Gynakol Geburtshilfliche Rundsch; 2006; 46(4):174-90. PubMed ID: 17068402
    [Abstract] [Full Text] [Related]

  • 2. [The benefits and risks of hormonal replacement therapy--an update].
    Schmidt M, Kimmig R.
    Gynakol Geburtshilfliche Rundsch; 2006; 46(4):166-73. PubMed ID: 17068401
    [Abstract] [Full Text] [Related]

  • 3. Could transdermal estradiol + progesterone be a safer postmenopausal HRT? A review.
    L'hermite M, Simoncini T, Fuller S, Genazzani AR.
    Maturitas; 2008; 60(3-4):185-201. PubMed ID: 18775609
    [Abstract] [Full Text] [Related]

  • 4. Use of dydrogesterone in hormone replacement therapy.
    Mueck AO, Seeger H, Bühling KJ.
    Maturitas; 2009 Dec; 65 Suppl 1():S51-60. PubMed ID: 19836909
    [Abstract] [Full Text] [Related]

  • 5. [Hormone therapy and risk for venous thromboembolism in postmenopausal women].
    Lacut K, Oger E.
    Rev Prat; 2005 Feb 28; 55(4):389-92. PubMed ID: 15828617
    [Abstract] [Full Text] [Related]

  • 6. Breast cancer risk during hormone therapy: experimental versus clinical data.
    Ruan X, Seeger H, Mueck AO.
    Minerva Endocrinol; 2012 Mar 28; 37(1):59-74. PubMed ID: 22382615
    [Abstract] [Full Text] [Related]

  • 7. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM, Fini M.
    Int J Fertil Womens Med; 2001 Mar 28; 46(5):248-56. PubMed ID: 11720197
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec 28; 15(6):453-65. PubMed ID: 11826770
    [Abstract] [Full Text] [Related]

  • 10. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H.
    Climacteric; 2003 May 28; 6 Suppl 1():11-36. PubMed ID: 12945798
    [Abstract] [Full Text] [Related]

  • 11. Postmenopausal hormone replacement therapy: does the progestin make a difference?
    Fylstra DL.
    J S C Med Assoc; 2002 Feb 28; 98(1):12-9. PubMed ID: 11859600
    [No Abstract] [Full Text] [Related]

  • 12. Increased thrombin generation among postmenopausal women using hormone therapy: importance of the route of estrogen administration and progestogens.
    Scarabin PY, Hemker HC, Clément C, Soisson V, Alhenc-Gelas M.
    Menopause; 2011 Aug 28; 18(8):873-9. PubMed ID: 21487317
    [Abstract] [Full Text] [Related]

  • 13. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
    Prescrire Int; 2004 Jun 28; 13(71):106-9. PubMed ID: 15233153
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR, Gadducci A, Gambacciani M.
    Climacteric; 2001 Sep 28; 4(3):181-93. PubMed ID: 11588941
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. New hormonal therapies and regimens in the postmenopause: routes of administration and timing of initiation.
    Sitruk-Ware R.
    Climacteric; 2007 Oct 28; 10(5):358-70. PubMed ID: 17852138
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.